BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12708472)

  • 1. Malignant rhabdoid tumor shows a unique neural differentiation as distinct from neuroblastoma.
    Higashino K; Narita T; Taga T; Ohta S; Takeuchi Y
    Cancer Sci; 2003 Jan; 94(1):37-42. PubMed ID: 12708472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant rhabdoid tumor shows incomplete neural characteristics as revealed by expression of SNARE complex.
    Yoshida S; Narita T; Taga T; Ohta S; Takeuchi Y
    J Neurosci Res; 2002 Sep; 69(5):642-52. PubMed ID: 12210830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of malignant rhabdoid tumor cell lines by reverse transcriptase-polymerase chain reaction.
    Suzuki A; Ohta S; Shimada M
    Diagn Mol Pathol; 1997 Dec; 6(6):326-32. PubMed ID: 9559292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The autocrine loop of epidermal growth factor receptor-epidermal growth factor / transforming growth factor-alpha in malignant rhabdoid tumor cell lines: heterogeneity of autocrine mechanism in TTC549.
    Narita T; Taga T; Sugita K; Nakazawa S; Ohta S
    Jpn J Cancer Res; 2001 Mar; 92(3):269-78. PubMed ID: 11267936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of pericyte, mesangium and muscle markers in malignant rhabdoid tumor cell lines: differentiation-induction using 5-azacytidine.
    Kato H; Ohta S; Koshida S; Narita T; Taga T; Takeuchi Y; Sugita K
    Cancer Sci; 2003 Dec; 94(12):1059-65. PubMed ID: 14662021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of neural stem cell markers in malignant rhabdoid tumor cell lines.
    Okuno K; Ohta S; Kato H; Taga T; Sugita K; Takeuchi Y
    Oncol Rep; 2010 Feb; 23(2):485-92. PubMed ID: 20043111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
    Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
    Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant rhabdoid tumor. A study with two established cell lines.
    Ota S; Crabbe DC; Tran TN; Triche TJ; Shimada H
    Cancer; 1993 May; 71(9):2862-72. PubMed ID: 8385567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in neuron-restrictive silencer factor (NRSF) mRNA levels during differentiation of cultured neuroblastoma cells.
    Nishimura E; Sasaki K; Maruyama K; Tsukada T; Yamaguchi K
    Neurosci Lett; 1996 Jun; 211(2):101-4. PubMed ID: 8830854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of chromogranin biosynthesis by neurotrophic growth factors in neuroblastoma cells.
    Weiss C; Winkler H; Laslop A
    Neurochem Int; 2001 Jan; 38(1):43-52. PubMed ID: 10913687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids.
    Schneider N; Lanz S; Ramer R; Schaefer D; Goppelt-Struebe M
    J Neurochem; 2001 Apr; 77(2):416-24. PubMed ID: 11299304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different regulation of mid-size neurofilament and N-myc mRNA expression during neuroblastoma cell differentiation induced by retinoic acid.
    Di Martino D; Ponzoni M; Cornaglia-Ferraris P; Tonini GP
    Cell Mol Neurobiol; 1990 Sep; 10(3):459-70. PubMed ID: 2123747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant rhabdoid-tumor cell line showing neural and smooth-muscle-cell phenotypes.
    Sugimoto T; Hosoi H; Horii Y; Ishida H; Mine H; Takahashi K; Abe T; Ohta S; Sawada T
    Int J Cancer; 1999 Aug; 82(5):678-86. PubMed ID: 10417765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
    Chen J; Chattopadhyay B; Venkatakrishnan G; Ross AH
    Cell Growth Differ; 1990 Feb; 1(2):79-85. PubMed ID: 1964795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse expression pattern of REST and synapsin I in human neuroblastoma cells.
    Lietz M; Cicchetti P; Thiel G
    Biol Chem; 1998 Oct; 379(10):1301-4. PubMed ID: 9820593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuron-specific splicing of zinc finger transcription factor REST/NRSF/XBR is frequent in neuroblastomas and conserved in human, mouse and rat.
    Palm K; Metsis M; Timmusk T
    Brain Res Mol Brain Res; 1999 Sep; 72(1):30-9. PubMed ID: 10521596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined evaluation of biochemical and morphological changes during human neuroblastoma cell differentiation.
    Lanciotti M; Montaldo PG; Folghera S; Lucarelli E; Cornaglia-Ferraris P; Ponzoni M
    Cell Mol Neurobiol; 1992 Jun; 12(3):225-40. PubMed ID: 1358448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene and protein expression profiling during differentiation of neuroblastoma cells triggered by 13-cis retinoic acid.
    Yuza Y; Agawa M; Matsuzaki M; Yamada H; Urashima M
    J Pediatr Hematol Oncol; 2003 Sep; 25(9):715-20. PubMed ID: 12972807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of hASH1 is associated with the retinoic acid-induced differentiation of human neuroblastoma cell lines.
    Ichimiya S; Nimura Y; Seki N; Ozaki T; Nagase T; Nakagawara A
    Med Pediatr Oncol; 2001 Jan; 36(1):132-4. PubMed ID: 11464865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent changes of chromogranin A/secretogranin II levels in differentiating human neuroblastoma cells.
    Weiler R; Meyerson G; Fischer-Colbrie R; Laslop A; PĂ„hlman S; Floor E; Winkler H
    FEBS Lett; 1990 Jun; 265(1-2):27-9. PubMed ID: 2365053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.